Compounds > norcantharidin
Page last updated: 2024-08-26

norcantharidin and Breast Neoplasms

norcantharidin has been researched along with Breast Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, H; Mou, D; Yang, G; Zhang, M; Zhao, L1
Chen, A; Cui, J; Jiang, Y; Li, L; Lian, L; Liu, Q; Qi, B; Qian, K; Qiu, Z; Zhang, B; Zhang, P; Zhang, X1
Chen, K; Dai, KS; Gong, FR; Li, W; Li, ZY; Lian, L; Mao, YX; Shou, LM; Tao, M; Xie, X; Zhang, QY1
Chen, Y; He, Q; Zhang, H1
Chang, FR; Chen, MF; Hu, DN; Kao, YH; Wu, YC; Yang, PY1
Chen, Z; Liu, D; Shi, P; Yin, X; Zhang, X1
Chao, KS; Chen, SH; Chen, WJ; Chen, YJ; Huang, WC; Kuo, CD; Liao, HF1

Other Studies

7 other study(ies) available for norcantharidin and Breast Neoplasms

ArticleYear
NCTD promotes Birinapant-mediated anticancer activity in breast cancer cells by downregulation of c-FLIP.
    Oncotarget, 2017, Apr-18, Volume: 8, Issue:16

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line, Tumor; Cell Survival; Dipeptides; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles

2017
Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cyclin-Dependent Kinase 3; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; MicroRNAs; Signal Transduction; Tamoxifen; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
    Oncology reports, 2013, Volume: 30, Issue:3

    Topics: Apoptosis; Blood Platelets; Blotting, Western; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cantharidin; Cell Adhesion; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Integrin alpha2; MCF-7 Cells; Platelet Adhesiveness; Protein Kinase C; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transcription Factor RelA; Wound Healing

2013
Involvement of bleomycin hydrolase and poly(ADP-ribose) polymerase-1 in Ubc9-mediated resistance to chemotherapy agents.
    International journal of oncology, 2017, Volume: 50, Issue:1

    Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Cysteine Endopeptidases; Deoxycytidine; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Enbucrilate; Etoposide; Female; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Poly (ADP-Ribose) Polymerase-1; Ubiquitin; Ubiquitin-Conjugating Enzymes; Vincristine

2017
Norcantharidin induces apoptosis of breast cancer cells: involvement of activities of mitogen activated protein kinases and signal transducers and activators of transcription.
    Toxicology in vitro : an international journal published in association with BIBRA, 2011, Volume: 25, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Cytochromes c; Drug Screening Assays, Antitumor; Female; Humans; Mitogen-Activated Protein Kinases; STAT Transcription Factors

2011
Effect of norcantharidin on the human breast cancer Bcap-37 cells.
    Connective tissue research, 2012, Volume: 53, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Cell Line, Tumor; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; G2 Phase; Humans; Membrane Potential, Mitochondrial; Reactive Oxygen Species

2012
Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Hedgehog Proteins; Humans; MCF-7 Cells; RNA, Messenger; Signal Transduction; Up-Regulation; Vinblastine; Vinorelbine

2012